Boothbay Fund Management, LLC Solid Biosciences Inc. Transaction History

Boothbay Fund Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.43 - $1.24 $25,703 - $74,121	-59,775 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.38 - $3.77 $142,264 - $225,351	59,775 New	59,775 $143,000
Q1 2021 May 17, 2021	SELL	$5.37 - $10.72 $404,344 - $807,183	-75,297 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$3.08 - $7.79 $14,057 - $35,553	4,564 Added 6.45%	75,297 $571,000
Q2 2020 Aug 14, 2020	BUY	$2.1 - $3.42 $38,037 - $61,946	18,113 Added 34.42%	70,733 $207,000
Q1 2020 May 15, 2020	BUY	$2.31 - $4.43 $92,617 - $177,616	40,094 Added 320.09%	52,620 $126,000
Q4 2019 Feb 14, 2020	BUY	$2.82 - $12.9 $35,323 - $161,585	12,526 New	12,526 $56,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $29.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.